<h2 id="introduction">Introduction</h2>
<p>During my career I have been mainly focused in the study of cancer biomarkers to identify patients at high risk of relapse after surgery and chemoresistance patients. To identify this patients, first, I dealed with pharmacogenomics, the study of polymorphisms and mutations in genes related with tretment metabolism and DNA repair occupied my first years of research.</p>
<p>After that stage, we begin to study the role of microRNAs in Cancer and recently I have extended my studies to other groups of non-coding RNAs, including lncRNAs, circRNAs or piwiRNAs.</p>
<p>I have worked in several tumor models including solid and hematologic malignancies but now I mainly focused in the study of non-coding RNAs in lung cancer.</p>
<p>Recently, I have also begin to work with liquid biopsies and extracellular vesicles (exosomes) and also I have begin to work with embryonic and lung cancer patients derived organoids.</p>
<p><strong>Interests:</strong> noncoding RNAs; microRNAs; piwiRNAs; lncRNAs; circularRNAs; extracellular vesicles; exosomes; biomarkers; lung cancer; colorectal cancer; lymphoma; leukemia; Hodgkin lymphoma; Multiple myeloma; organoids;</p>
<h2 id="publications">Publications</h2>
<p>To see a list with all of Alfons Navarro’s papers you can visit <a href="https://scholar.google.es/citations?user=xF42u88AAAAJ&amp;hl=en">Google Scholar</a> or Alfons’s ORCID <a href="https://orcid.org/0000-0001-6071-0926">0000-0001-6071-0926</a></p>
<p>Below we have included selected papers describing some of our best known work.</p>
<h4 id="reviews">Reviews</h4>
<p>-<a href="https://pubmed.ncbi.nlm.nih.gov/29161231/">Epigenetic regulation mechanisms of microRNA expression.</a> S Morales, M Monzo, A Navarro. Biomolecular concepts 8 (5-6), 203-212.</p>
<p>-<a href="https://pubmed.ncbi.nlm.nih.gov/28555062/">Non-coding RNAs in Hodgkin lymphoma.</a> A Cordeiro, M Monzó, A Navarro. International journal of molecular sciences 18 (6), 1154.</p>
<p>-<a href="http://atlasgeneticsoncology.org/Genes/GC_MIR135A1.html">MIR135A1 (microRNA 135a-1).</a> A Navarro, M Díaz-Beyá, M Monzó. Atlas of Genetics and Cytogenetics in Oncology and Haematology.</p>
<p>-<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908867/">MicroRNAs in human embryonic and cancer stem cells.</a> A Navarro, M Monzó. Yonsei medical journal 51 (5), 622-632.</p>
<p>-<a href="https://pubmed.ncbi.nlm.nih.gov/18940743/">Pharmacogenomics: a tool for improving cancer chemotherapy.</a> M Monzo, A Navarro, G Ferrer, R Artells. Clinical and Translational Oncology 10 (10), 628-637.</p>
<h4 id="editorials">Editorials</h4>
<p>-<a href="https://tcr.amegroups.com/article/view/48756">Clinic and therapeutic potential of non-coding RNAs in cancer.</a> JJ Castellano, M Diaz-Beya, A Navarro. Transl Cancer Res 10 (6).</p>
<p>-<a href="https://ncri.amegroups.com/article/view/5871/html">Can long non-coding RNAs reveal the hidden code of lung cancer?.</a> JJ Castellano, A Navarro. Non-coding RNA Investigation, 2020, vol. 4, num. 6.</p>
<p>-<a href="https://tcr.amegroups.com/article/view/26206/html">Twist1 activated circRNA-10720 is a new player in hepatocellular carcinoma metastasis.</a> A Navarro. Transl Cancer Res 8 (S2), S135-S140.</p>
<p>-<a href="https://ncri.amegroups.com/article/view/3924/4567">Argonaute-crosslinking and immunoprecipitation deciphers the liver miR-122 targetome.</a> A Navarro. Non-coding RNA Investig 1, 23.</p>
<p>-<a href="https://doi.org/10.2217/14622416.10.3.335">Genotypes and chemotherapy toxicity.</a> M Monzo, A Navarro. Pharmacogenomics vol. 10, num. 3.</p>
<p>-<a href="https://doi.org/10.2217/14622416.10.3.335">Genetic Predictors of Leukocytopenia severity.</a> M Monzo, A Navarro. Pharmacogenomics vol. 10, num. 3.</p>
<h4 id="micrornas">MicroRNAs</h4>
<p>-miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. E Gallardo, A Navarro, N Vinolas, RM Marrades, T Diaz, B Gel, A Quera, … Carcinogenesis 30 (11), 1903-1909.</p>
<p>-Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. M Monzo, A Navarro, E Bandres, R Artells, I Moreno, B Gel, R Ibeas, … Cell research 18 (8), 823-833.</p>
<p>-MicroRNA expression profiling in classic Hodgkin lymphoma. A Navarro, A Gaya, A Martinez, A Urbano-Ispizua, A Pons, O Balagué, … Blood, The Journal of the American Society of Hematology 111 (5), 2825-2832.</p>
<p>-Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma. A Navarro, T Diaz, A Martinez, A Gaya, A Pons, B Gel, C Codony, G Ferrer, … Blood, The Journal of the American Society of Hematology 114 (14), 2945-2951.</p>
<p>-Acute myeloid leukemia with translocation (8; 16)(p11; p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene. M Diaz-Beya, A Navarro, G Ferrer, T Diaz, B Gel, M Camos, M Pratcorona, … Leukemia 27 (3), 595-603.</p>
<p>-MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia. M Diaz-Beya, S Brunet, J Nomdedeu, R Tejero, T Diaz, M Pratcorona, … Leukemia 28 (4), 804-812</p>
<h4 id="lncrnas">LncRNAs</h4>
<p>-LincRNA-p21 impacts prognosis in resected non–small cell lung Cancer patients through angiogenesis regulation JJ Castellano, A Navarro, N Viñolas, RM Marrades, J Moises, A Cordeiro, … Journal of Thoracic Oncology 11 (12), 2173-2182.</p>
<h4 id="piwirnas">PiwiRNAs</h4>
<p>-PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma A Cordeiro, A Navarro, A Gaya, M Díaz-Beyá, B Gonzalez-Farré, … Oncotarget 7 (29), 46002-46013.</p>
<p>-The significance of PIWI family expression in human lung embryogenesis and non-small cell lung cancer A Navarro, R Tejero, N Viñolas, A Cordeiro, RM Marrades, D Fuster, … Oncotarget 6 (31), 31544.</p>
<h4 id="circrnas">CircRNAs</h4>
<p>-<a href="https://pubmed.ncbi.nlm.nih.gov/34012794/">Role of the epithelial-mesenchymal transition-related circular RNA, circ-10720, in non-small-cell lung cancer.</a> J Martín, JJ Castellano, RM Marrades, J Canals, N Viñolas, T Díaz, … Translational Lung Cancer Research 10 (4), 1804</p>
<h4 id="extracellular-vesicles-exosomes-and-non-coding-rnas">Extracellular vesicles (exosomes) and non-coding RNAs</h4>
<p>-Extracellular vesicle lincRNA-p21 expression in tumor-draining pulmonary vein defines prognosis in NSCLC and modulates endothelial cell behavior JJ Castellano, RM Marrades, L Molins, N Viñolas, J Moises, J Canals, … Cancers 12 (3), 734</p>
<p>-Exosome analysis in tumor-draining pulmonary vein identifies NSCLC patients with higher risk of relapse after curative surgery A Navarro, L Molins, RM Marrades, J Moises, N Viñolas, S Morales, … Cancers 11 (2), 249</p>
<h4 id="pharmacogenomics">Pharmacogenomics</h4>
<p>-Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation. CF de Larrea, A Navarro, R Tejero, N Tovar, T Díaz, MT Cibeira, L Rosinol, … Clinical cancer research 18 (13), 3697-3704.</p>
<p>-Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia. M Monzo, S Brunet, A Urbano-Ispizua, A Navarro, G Perea, J Esteve, … Blood 107 (12), 4871-4879.</p>
<p>-MiR-SNPs as markers of toxicity and clinical outcome in Hodgkin lymphoma patients. A Navarro, C Munoz, A Gaya, M Díaz-Beyá, B Gel, R Tejero, T Díaz, … PloS one 8 (5), e64716</p>
<p>-A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma. M Campayo, A Navarro, N Vinolas, R Tejero, C Munoz, T Diaz, … PloS one 6 (7), e22509</p>
<p>-Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with … J Carles, M Monzo, M Amat, S Jansa, R Artells, A Navarro, P Foro, … International Journal of Radiation Oncology* Biology* Physics 66 (4), 1022-1030.</p>
<p>-Common variants in NLRP2 and NLRP3 genes are strong prognostic factors for the outcome of HLA-identical sibling allogeneic stem cell transplantation M Granell, A Urbano-Ispizua, A Pons, JI Aróstegui, B Gel, A Navarro, … Blood, The Journal of the American Society of Hematology 112 (10), 4337-4342</p>
